Clinical trial ZEST
A Randomized Phase 3 Double-Blinded Study Comparing Efficacy of Niraparib to Placebo in Participants with Either HER2-Negative BRCA-Mutated or Triple-Negative Breast Cancer with Molecular Disease Based on Presence of Circulating Tumor DNA after Definitive Therapy
Cancers | |
---|---|
Organ | Breast |
Trial status | Trial closed for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 3 |
Academic trial | Non |
Sponsor | GSK |
EudraCT Identifier | 2020-003973-23 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04915755 |
Last update |